|
Volumn 72, Issue 3, 2002, Pages 221-226
|
True positive somatostatin receptor scintigraphy in primary breast cancer correlates with expression of sst2A and sst5
a a a a a a |
Author keywords
Antibody; Breast cancer; Immunocytochemistry; Octreotide; Scintigraphy; Somatostatin receptor
|
Indexed keywords
ANTIBODY;
PENTETREOTIDE IN 111;
RECEPTOR SUBTYPE;
SOMATOSTATIN 2A RECEPTOR;
SOMATOSTATIN 5 RECEPTOR;
SOMATOSTATIN RECEPTOR;
UNCLASSIFIED DRUG;
BIOLOGICAL MARKER;
DIAGNOSTIC AGENT;
DRUG DERIVATIVE;
INDIUM;
OCTREOTIDE;
PENTETIC ACID;
SDZ 215 811;
SDZ 215-811;
SOMATOSTATIN RECEPTOR 5;
SOMATOSTATIN RECEPTOR SST2A;
ADULT;
AGED;
ARTICLE;
BINDING SITE;
BREAST CANCER;
CLINICAL ARTICLE;
FEMALE;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
METASTASIS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SCINTIGRAPHY;
BREAST TUMOR;
LABORATORY DIAGNOSIS;
MIDDLE AGED;
PATHOLOGY;
PROSPECTIVE STUDY;
SCINTISCANNING;
ADULT;
AGED;
AGED, 80 AND OVER;
BIOLOGICAL MARKERS;
BREAST NEOPLASMS;
FALSE NEGATIVE REACTIONS;
FEMALE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
INDIUM RADIOISOTOPES;
MIDDLE AGED;
OCTREOTIDE;
PENTETIC ACID;
PROSPECTIVE STUDIES;
RECEPTORS, SOMATOSTATIN;
|
EID: 0036010911
PISSN: 01676806
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1014972520302 Document Type: Article |
Times cited : (29)
|
References (15)
|